Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Achieving SVR Does Not Prevent From Fibrosis Progession In Patients With FCH Results From A Large French Prospective Multicentric ANRS CO23 Cupilt CohortHepatology, 2017, 66, pp.872A-872A
Journal articles
hal-01769633v1
|
|||
Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO studyEuropean Journal of Gastroenterology & Hepatology, 2018, 30 (3), pp.302-309. ⟨10.1097/MEG.0000000000001035⟩
Journal articles
hal-01717743v1
|